Leucine-Rich Repeat Kinase 2 Regulates Mitochondria for Zygotic Genome Activation in Mouse Early Embryos
Yu-Lan Lu1, Zi-Yu Wei2,3, Xiao-Ting Yu1,3
1Key Laboratory of Research on Clinical Molecular Diagnosis for High Incidence Diseases in Western Guangxi of Guangxi Higher Education Institutions, Reproductive Medicine of Guangxi Medical and Health Key Discipline Construction Project, Affiliated Hospital of Youjiang Medical University for Nationalities, Zhongshan 2 Road, Youjiang District, Baise 533000, China.
Abstract:
Leucine-rich repeat kinase 2 (LRRK2) is a multidomain protein known for its involvement in neurodegenerative disorders, particularly Parkinson's disease, where it is considered one of the most common genetic contributors. LRRK2 plays multiple roles in cellular signaling, protein trafficking, and cytoskeletal dynamics. In present study, using mouse as the mammalian model, we reported its important roles in early embryo development. We showed that LRRK2 accumulated around nucleus before two-cell stage but distributed in the cytoplasm of blastomeres after four-cell stage. Loss of LRRK2 activity induced two-cell to four-cell transition defects, indicating the failure of zygotic genome activation during embryo development. We showed the mitochondria dysfunction after LRRK2 inhibition, since the mitochondria distribution, intensity, ATP production, and mitochondria number were all altered. This might further induce the evaluated ROS level for the occurrence of oxidative stress. Besides, we also observed that the cortex and cytoplasmic actin in the blastomere of embryos were decreased, which further linked with mitochondria. In summary, we showed that LRRK2 activity is essential for actin-based mitochondria distribution and function, which further controls the occurrence of oxidative stress for mouse early embryo development.
Insights
Leucine-rich repeat kinase 2 (LRRK2) is crucial for early mouse embryo development. Its activity ensures proper cell division, mitochondrial function, and prevents oxidative stress, vital for successful embryonic growth.
Area of Science:
- Developmental Biology
- Cell Biology
- Genetics
Background:
- Leucine-rich repeat kinase 2 (LRRK2) is implicated in neurodegenerative diseases like Parkinson's.
- LRRK2's known roles include cellular signaling, protein trafficking, and cytoskeletal dynamics.
- Its function in early mammalian embryo development remains largely unexplored.
Purpose of the Study:
- To investigate the role of Leucine-rich repeat kinase 2 (LRRK2) in early mouse embryo development.
- To elucidate the cellular mechanisms by which LRRK2 influences embryonic progression.
Main Methods:
- Utilized a mouse model to study Leucine-rich repeat kinase 2 (LRRK2) function.
- Observed LRRK2 localization during early embryonic stages (two-cell to four-cell transition).
- Assessed effects of LRRK2 inhibition on zygotic genome activation, mitochondrial function, and actin dynamics.
Main Results:
- LRRK2 localization shifts from nuclear to cytoplasmic during early embryonic development.
- Inhibition of LRRK2 activity impairs the two-cell to four-cell transition, indicating failed zygotic genome activation.
- LRRK2 deficiency leads to mitochondrial dysfunction (altered distribution, intensity, ATP production, number) and increased reactive oxygen species (ROS) and decreased actin.
Conclusions:
- Leucine-rich repeat kinase 2 (LRRK2) activity is essential for successful early mouse embryo development.
- LRRK2 regulates actin-based mitochondrial distribution and function, thereby controlling oxidative stress.
- Proper LRRK2 function is critical for zygotic genome activation and overall embryonic viability.
Related Concept Videos
Formation of Muscle Fibers from Myoblasts
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
MAPK Signaling Cascades
PI3K/mTOR/AKT Signaling Pathway
Animal Mitochondrial Genetics
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Master Transcription Regulators


